fda
FDA approves Keytruda as adjuvant treatment for kidney cancer
The cancer immunotherapy drug Keytruda (pembrolizumab), was approved Thursday by the U.S. Food and Drug Administration (FDA) to help in ...
FDA plans to authorize Pfizer boosters for all adults before week’s end: reports
The U.S. Food and Drug Administration (FDA) is expected to authorize booster doses of the Pfizer/BioNTech COVID-19 vaccine for all ...
Biden picks former FDA chief Califf to again lead agency-
By PTI WASHINGTON: President Joe Biden on Friday is tapping former Food and Drug Administration commissioner Robert Califf to again ...
Pfizer asks FDA to greenlight COVID-19 booster shots for all adults-
By PTI Pfizer asked U.S. regulators on Tuesday, November 9, 2021, to allow boosters of its COVID-19 vaccine for anyone ...
Emergency use authorization request filed with FDA for paediatric use of Bharat Biotech’s Covaxin-
By PTI HYDERABAD: Ocugen Inc., Bharat Biotech’s partner for USA and Canada for COVID-19 vaccine Covaxin on Friday, November 5, ...
FDA delaying decision on its shot for adolescents: Moderna
The U.S. Food and Drug Administration told the company Friday evening that its review could last until January, Moderna said. ...
FDA announces new breast implant restrictions, orders stronger warnings
The U.S. Food and Drug Administration (FDA) announced Wednesday that it had taken new actions to strengthen breast implant risk ...
Bharat Biotech’s US partner Ocugen files request with FDA for Covaxin trials-
By PTI HYDERABAD: Ocugen, Bharat Biotech’s US partner for COVID-19 vaccine Covaxin, on Wednesday said it has submitted Investigational New ...
FDA says Pfizer Covid-19 vaccine looks effective for young kids-
By Associated Press WASHINGTON: Federal health regulators said late Friday that kid-size doses of Pfizer’s COVID-19 vaccine appear highly effective ...
FDA may approve mixing and matching COVID-19 booster shots
The U.S. Food and Drug Administration (FDA) is expected to allow the mixing and matching of COVID-19 vaccine booster doses ...
